Patents by Inventor Dov Tamarkin

Dov Tamarkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082136
    Abstract: A topical composition for application to the skin, comprising an amino acid, which is a nitric oxide donor.
    Type: Application
    Filed: January 13, 2022
    Publication date: March 14, 2024
    Inventors: Eyal S. RON, Dov TAMARKIN, Avner SHEMER
  • Publication number: 20230355493
    Abstract: A topical composition for application to the skin, comprising an amino acid, which is a nitric oxide donor.
    Type: Application
    Filed: July 13, 2023
    Publication date: November 9, 2023
    Inventors: Eyal S. RON, Dov TAMARKIN, Avner SHEMER
  • Publication number: 20230355500
    Abstract: A topical composition for application to the skin, comprising an NO-donor and a counter-NO agent, which balances the effect of the NO-donor in the skin. The present invention relates to novel topical compositions designed for application to the skin. The composition comprises an NO-donor, which serves as a source of nitric oxide, and a counter-NO agent that acts to balance the effects of the NO-donor on the skin. The combined use of the NO-donor and the counter-NO agent in the composition provides a unique and beneficial therapeutic effect.
    Type: Application
    Filed: July 13, 2023
    Publication date: November 9, 2023
    Inventors: Eyal S. RON, Dov TAMARKIN, Avner SHEMER
  • Publication number: 20230270760
    Abstract: Methods of treatment and dosage regimes using hydrophobic gel or foam composition comprising a tetracycline antibiotic in treating or alleviating a disorder including, acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. acnes bacteria associated disorders and other superficial infections, including skin infections wherein the foam composition or gel is administered topically to a target area on a subject having the disorder and wherein the target area comprises an area of skin.
    Type: Application
    Filed: September 29, 2022
    Publication date: August 31, 2023
    Inventors: Dov Tamarkin, Elana Gazal, Rita Keynan, Meir Eini, David Schuz
  • Patent number: 11433025
    Abstract: A waterless foamable pharmaceutical composition suitable for external administration is disclosed. The composition includes a foamable carrier least one liquefied or compressed gas propellant. The foamable carrier includes at least one liquid oil; at least one silicone and at least one least one stabilizing agent; wherein the stabilizing agent selected from the group consisting of about 0.01% to about 25% by weight of at least one surface-active agent alone or on combination with a foam adjuvant; and about 0% to about 5% by weight of at least one polymeric agent alone or on combination with a foam adjuvant; and mixtures thereof. Pharmaceutical compositions comprising active agents, methods for their preparation, propellants suitable for use with the carriers and uses thereof are further described.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: September 6, 2022
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Helena Shifrin, Rita Keynan, Enbal Ziv, Tal Berman, David Schuz, Elana Gazal
  • Patent number: 11324691
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: May 10, 2022
    Assignee: Journey Medical Corporation
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Patent number: 11219631
    Abstract: A substantially surface active agent-free foamable composition which includes short-chain alcohol, water, polymer, fatty alcohol or fatty acid or a combination of fatty alcohol and fatty acid and propellant. A substantially surface active agent-free foamable composition which includes, water, polymer, fatty alcohol or fatty acid and propellant. A method of treatment using a substantially surface active agent-free foamable compositions.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: January 11, 2022
    Assignee: Vyne Pharmaceuticals Inc.
    Inventors: Dov Tamarkin, Enbal Ziv, Yohan Hazot, David Schuz
  • Publication number: 20210386944
    Abstract: A gas-evolving composition delivery system is disclosed, which comprises a pressurized container having a dispenser, and a liquid gas-evolving composition, such as an acidified nitrite solution, within the pressurized container, wherein the pressurized container has an internal pressure sufficient to minimize gas production from the gas-evolving composition while within the container. Also disclosed is a method of stabilizing an acidified nitrite solution comprising loading the solution into a container and sealing the container to be airtight.
    Type: Application
    Filed: October 14, 2019
    Publication date: December 16, 2021
    Applicant: SaNOtize Research Development Corp.
    Inventors: Dov Tamarkin, Gilly Regev, Christopher C. Miller
  • Patent number: 11103454
    Abstract: Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided. In some embodiments, the wax is a liquid wax. In some embodiments, the wax includes a solid wax and a liquid wax. The compositions are substantially free of crystals. The components are selected to provide a composition that is substantially resistant to aging and to phase separation, and/or can substantially solubilize and or stabilize active ingredients. Pharmaceutical and cosmetic compositions with potentially enhanced skin delivery and their uses are also provided.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: August 31, 2021
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Rita Keynan, David Schuz, Tal Berman
  • Publication number: 20210205212
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Application
    Filed: October 20, 2020
    Publication date: July 8, 2021
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Patent number: 11033491
    Abstract: The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients. The invention further relates to a foamable composition further containing a liquefied hydrocarbon gas propellant.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: June 15, 2021
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Doron Friedman, Tal Berman, Enbal Ziv, David Schuz
  • Patent number: 10967063
    Abstract: A substantially surface active agent-free and foam adjuvant-free composition which includes a hydrophobic solvent, a wax and a propellant. A substantially surface active agent-free and foam adjuvant-free composition, further comprising, a tetracycline antibiotic, or one or more other active agents. A method of treatment, using a substantially surface active agent-free and substantially foam adjuvant-free composition.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: April 6, 2021
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • Publication number: 20210077509
    Abstract: Methods of treatment and dosage regimes using hydrophobic gel or foam composition comprising a tetracycline antibiotic in treating or alleviating a disorder including, acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. acne bacteria associated disorders and other superficial infections, including skin infections wherein the foam composition or gel is administered topically to a target area on a subject having the disorder and wherein the target area comprises an area of skin.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 18, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Rita Keynan, Meir Eini, David Schuz
  • Patent number: 10946101
    Abstract: A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: March 16, 2021
    Assignee: Vyne Therapeutics Inc.
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • Publication number: 20210069335
    Abstract: The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
    Type: Application
    Filed: October 1, 2020
    Publication date: March 11, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Yohan Hazot, David Schuz, Irakliy Papiashvili
  • Publication number: 20210038517
    Abstract: The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients. The invention further relates to a foamable composition further containing a liquefied hydrocarbon gas propellant.
    Type: Application
    Filed: October 16, 2020
    Publication date: February 11, 2021
    Inventors: Dov Tamarkin, Doron Friedman, Tal Berman, Enbal Ziv, David Schuz
  • Publication number: 20210023226
    Abstract: A substantially surface active agent-free and foam adjuvant-free composition which includes a hydrophobic solvent, a wax and a propellant. A substantially surface active agent-free and foam adjuvant-free composition, further comprising, a tetracycline antibiotic, or one or more other active agents. A method of treatment, using a substantially surface active agent-free and substantially foam adjuvant-free composition.
    Type: Application
    Filed: October 9, 2020
    Publication date: January 28, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • Publication number: 20210015928
    Abstract: The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
    Type: Application
    Filed: September 29, 2020
    Publication date: January 21, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Yohan Hazot, David Schuz, Irakliy Papiashvili
  • Publication number: 20210015927
    Abstract: A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
  • Patent number: 10849847
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: December 1, 2020
    Assignee: Foamix Pharamaceuticals Ltd.
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan